Your browser doesn't support javascript.
loading
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis.
Levin, Myron J; Divino, Victoria; Shah, Drishti; DeKoven, Mitch; Mould-Quevedo, Joaquin; Pelton, Stephen I; Postma, Maarten J.
Affiliation
  • Levin MJ; Departments of Pediatrics and Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA.
  • Divino V; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • Shah D; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • DeKoven M; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • Mould-Quevedo J; Global Pricing & Health Economics, Seqirus USA Inc., Summit, NJ 07901, USA.
  • Pelton SI; Department of Pediatrics, Boston University Schools of Medicine, Boston, MA 02118, USA.
  • Postma MJ; Division of Pediatric Infectious Diseases, Maxwell Finland Laboratory, Boston Medical Center, Boston, MA 02118, USA.
Vaccines (Basel) ; 9(10)2021 Oct 08.
Article in En | MEDLINE | ID: mdl-34696254
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country: Country of publication: